Director
DIN: 00191276
Jawed Zia is currently associated with 3 companies as Director. They serve as a Director at ACTURE HEALTH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00191276.Jawed Zia has previously been associated with 9 companies in roles such as Additional Director, Managing Director, Director and Whole-time director.Jawed Zia is currently involved in 1 different role. Their most recent position is with NILOCAS INDIA PRIVATE LIMITED as a Director. The first company Jawed Zia was appointed to as a director was ACTURE HEALTH PRIVATE LIMITED. Jawed Zia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jawed Zia is currently associated with 3 companies as Director. They serve as a Director at ACTURE HEALTH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00191276.Jawed Zia has previously been associated with 9 companies in roles such as Additional Director, Managing Director, Director and Whole-time director.Jawed Zia is currently involved in 1 different role. Their most recent position is with NILOCAS INDIA PRIVATE LIMITED as a Director. The first company Jawed Zia was appointed to as a director was ACTURE HEALTH PRIVATE LIMITED. Jawed Zia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (0)
Past Companies (9)
4y 3m 2y 2m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ACTURE HEALTH PRIVATE LIMITED | Director | 10-Nov-2022 |
| INDISUAN PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2025 |
| NILOCAS INDIA PRIVATE LIMITED | Director | 21-Apr-2026 |